The Food and Drug Administration on Tuesday announced that it had authorized an additional batch of Johnson & Johnson COVID-19 vaccine that had been produced from a troubled Baltimore facility.
Regeneron’s COVID-19 therapy was found to reduce the risk of death in hospitalized patients who had not mounted their own immune response to the virus by up to 20%, the company said Wednesday
An Arizona family is mourning the death of their 24-year-old daughter who they claim sought weight loss surgery in Mexico and later died in a hospital in her home state due to complications from the procedure.
Reports of heart inflammation among a small fraction of Pfizer and Moderna COVID-19 vaccine recipients, predominantly males under 30, are under review as an advisory panel to the Centers for Disease Control and Prevention is set to meet Friday.
New York Gov. Andrew Cuomo announced Tuesday that all remaining COVID-19 restrictions "would be relaxed as of today" after the state reached its goal of vaccinating 70% of the adult population, but mask-wearing would remain in effect for some.
The U.S. recorded a grim milestone Tuesday with over 600,000 deaths attributed to coronavirus, according to data from Johns Hopkins University. However, the news comes as weekly fatalities have declined to lows not seen since early on in the pandemic.
Hawaiian health officials said Monday that a fully vaccinated resident who traveled to Nevada last month has since tested positive for the Delta coronavirus variant.
A small study offers the first hint that an extra dose of COVID-19 vaccines just might give some organ transplant recipients a needed boost in protection.
Maryland-based biotech company Novavax on Monday announced its experimental COVID-19 vaccine remained effective when coadministered with an approved flu shot.
A study out of Scotland has found the Delta COVID-19 variant carries double the risk of hospitalization compared to the Alpha strain, particularly in patients with five or more comorbidities.
The U.K. will face another four weeks of COVID-19-related restrictions, Prime Minister Boris Johnson announced Monday amid concerns of rapid spread of a highly transmissible Delta variant.
A top expert with the U.K.’s Scientific Advisory Group for Emergencies (SAGE) on Sunday warned the region is approaching a third wave of COVID-19 infections as a highly transmissible variant first detected in India continues to proliferate.
The former head of the FDA said that while the Delta variant currently accounts for about 10% of coronavirus infections in the U.S., it’s doubling at a rate of every two weeks meaning "it’s probably going to become the dominant strain."
